Trial Profile
Sitagliptin Utilization in Diabetic Patients with Coronary Artery Disease for Improving Cardiovascular Outcomes (SUPERIOR study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Oct 2013
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SUPERIOR
- 02 Oct 2013 New trial record